EURURO Vol. 73 No. 1

e u r o p e a n u r o l o g y , vo l . 7 3 , n o . 1 , J a nu a ry 2 0 1 8

Papillary Renal Cell Carcinoma: A Family Portrait

R. Flippot, E. Compérat, N.M. Tannir, G.G. Malouf

Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis

S. Woo, C.H. Suh, S.Y. Kim, J.Y. Cho, S.H. Kim

Contemporary magnetic resonance imaging shows excellent per-patient sensitivity

and specificity for the detection of bone metastasis in patients with prostate cancer.

Using two or more imaging planes may further improve sensitivity, while excellent

diagnostic performance was observed across various subgroups.

Magnetic Resonance Imaging and Detection of Metastases in Prostate Cancer: Learning Lessons from History

A.P. Hoyle, N.W. Clarke

The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review

R. Boissier, V. Hevia, H.M. Bruins, K. Budde, A. Figueiredo, E. Lledó-García, J. Olsburgh, H. Regele,

C.F. Taylor, R.H. Zakri, C.Y. Yuan, A. Breda

Immunosuppression after renal transplant does not affect the natural history

and the outcomes of low-risk renal cell carcinoma and prostate cancer. Considering

the high risk of recurrence for upper urinary tract carcinoma, close follow-up

or bilateral nephroureterectomy are both possible strategies.

109

Renal Transplantation After Treatment for a Urological Cancer: Who and When? Does Evidence Help for a Challenge?

J. Burgos-Revilla, V. Gomez-Dos Santos

111

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

M. Rouprêt, M. Babjuk, E. Compérat, R. Zigeuner, R.J. Sylvester, M. Burger, N.C. Cowan,

P. Gontero, B.W.G. Van Rhijn, A.H. Mostafid, J. Palou, S.F. Shariat

These guidelines provide information on the management of individual patients

according to a current standardised approach. Urologists should take into account

the specific clinical characteristics of each patient when determining the optimal

treatment regimen, based on the proposed risk stratification of these tumours.

In patients with low-risk tumours and two functional kidneys, kidney-sparing

management should be offered as the primary treatment option.

123

Lateral-based Anterior Vaginal Wall Flap in the Treatment of Female Urethral Stricture: Efficacy and Safety

J. Romero-Maroto, L. Verdú-Verdú, L. Gómez-Pérez, C. Pérez-Tomás,

J.-J. Pacheco-Bru, A. López-López

Lateral based vaginal flap is a reliable, effective, and long-lasting technique to treat

female urethral stricture, with no apparent secondary effects.

129

A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease

S.K. Van Den Eeden, R. Lu, N. Zhang, C.P. Quesenberry Jr., J. Shan, J.S. Han, A.C. Tsiatis,

A.D. Leimpeter, H.J. Lawrence, P.G. Febbo, J.C. Presti

A biopsy-based assay—the Genomic Prostate Score (GPS)—has been shown

to predict that a patient with prostate cancer has high-grade and high-stage

disease. This study shows that GPS is also a strong independent predictor

of metastases and prostate cancer death.

Prostatic Disease

Renal Disease

Guidelines

Surgery in Motion

Original Article

Prostate Cancer